Citigroup
COV

Citigroup’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Citigroup’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-967,500
Closed -$99M – 7821
2014
Q4 		$99M Sell
967,500
-393,600
-29% -$37.8M 0.09% 215
2014
Q3 		$118M Buy
1,361,100
+632,600
+87% +$56M 0.1% 162
2014
Q2 		$65.7M Buy
728,500
+675,100
+1,264% +$50.5M 0.06% 287
2014
Q1 		$3.93M Sell
53,400
-66,800
-56% -$4.66M ﹤0.01% 1886
2013
Q4 		$8.19M Buy
120,200
+48,400
+67% +$3.15M 0.01% 1400
2013
Q3 		$4.38M Buy
71,800
+9,873
+16% +$602K ﹤0.01% 1865
2013
Q2 		$3.45M Buy
+61,927
New +$3.58M ﹤0.01% 1969

Citigroup's COV Position: Q1 2015 in Review

Citigroup sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,729,185 shares — an estimated $279M sold.

Citigroup first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $279M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Citigroup reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 2,729,185 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $279M.
  • Citigroup first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Citigroup's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $279M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.